PDGF Antibodies

Santa Cruz Biotechnology features a diverse variety of PDGF Antibodies for studying platelet-derived growth factor (PDGF) signaling pathways. PDGF Antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDGF plays a crucial role in cell growth, proliferation, and angiogenesis, making it a significant factor in wound healing and tissue repair. Dysregulation of PDGF signaling has been implicated in various diseases, including cancer and fibrotic disorders. Research focused on PDGF signaling pathways continues to reveal potential therapeutic targets for treating various pathological conditions. PDGF monoclonal antibodies enable detailed analysis of cellular responses and molecular interactions in both normal and disease states. Understanding PDGF's function can provide insights into therapeutic targets for multiple conditions. Investigating PDGF signaling mechanisms helps advance knowledge of cellular processes and disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of PDGF's role in human health and disease.